Centennial Wealth Advisory LLC Has $475,000 Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Centennial Wealth Advisory LLC raised its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 9.7% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 906 shares of the healthcare conglomerate’s stock after acquiring an additional 80 shares during the period. Centennial Wealth Advisory LLC’s holdings in UnitedHealth Group were worth $475,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also modified their holdings of UNH. Capital & Planning LLC raised its stake in shares of UnitedHealth Group by 19.2% in the fourth quarter. Capital & Planning LLC now owns 491 shares of the healthcare conglomerate’s stock worth $248,000 after acquiring an additional 79 shares during the last quarter. Brighton Jones LLC raised its position in UnitedHealth Group by 176.2% in the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock worth $22,384,000 after purchasing an additional 28,231 shares during the last quarter. Union Bancaire Privee UBP SA bought a new position in UnitedHealth Group in the 4th quarter valued at $27,233,000. Revolve Wealth Partners LLC raised its position in shares of UnitedHealth Group by 137.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock worth $2,033,000 after acquiring an additional 2,324 shares during the last quarter. Finally, Bank Pictet & Cie Europe AG boosted its holdings in UnitedHealth Group by 3.9% in the fourth quarter. Bank Pictet & Cie Europe AG now owns 263,655 shares of the healthcare conglomerate’s stock valued at $133,373,000 after acquiring an additional 9,872 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $306.90 on Thursday. The company has a fifty day moving average price of $370.86 and a 200 day moving average price of $467.96. UnitedHealth Group Incorporated has a 1-year low of $248.88 and a 1-year high of $630.73. The firm has a market cap of $278.40 billion, a PE ratio of 12.85, a PEG ratio of 1.45 and a beta of 0.44. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). The firm had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. During the same period in the prior year, the business posted $6.91 EPS. Research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 24th. Investors of record on Monday, June 16th will be given a $2.21 dividend. The ex-dividend date is Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.88%. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.10. UnitedHealth Group’s payout ratio is currently 37.02%.

Insider Activity at UnitedHealth Group

In other news, Director Kristen Gil acquired 3,700 shares of the stock in a transaction dated Thursday, May 15th. The shares were bought at an average cost of $271.17 per share, for a total transaction of $1,003,329.00. Following the purchase, the director now directly owns 3,818 shares of the company’s stock, valued at approximately $1,035,327.06. This trade represents a 3,135.59% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Timothy Patrick Flynn purchased 1,533 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, May 14th. The shares were acquired at an average price of $320.80 per share, with a total value of $491,786.40. Following the acquisition, the director now directly owns 6,033 shares of the company’s stock, valued at $1,935,386.40. This trade represents a 34.07% increase in their position. The disclosure for this purchase can be found here. Over the last ninety days, insiders purchased 109,408 shares of company stock valued at $31,607,768. Insiders own 0.28% of the company’s stock.

Analyst Ratings Changes

UNH has been the topic of several recent research reports. HSBC reaffirmed a “reduce” rating and issued a $270.00 target price (down previously from $490.00) on shares of UnitedHealth Group in a research note on Wednesday, May 21st. Mizuho reduced their price objective on shares of UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating on the stock in a research note on Friday, May 16th. TD Securities reissued a “hold” rating and issued a $308.00 price target (down previously from $520.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. Oppenheimer dropped their price objective on UnitedHealth Group from $600.00 to $400.00 and set an “outperform” rating for the company in a report on Wednesday, May 14th. Finally, Robert W. Baird cut UnitedHealth Group from an “outperform” rating to a “neutral” rating and set a $312.00 target price on the stock. in a report on Wednesday, June 11th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $426.52.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.